Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 731

1.

Progressive Renal Dysfunction due to IgG4-Related Kidney Disease Refractory to Steroid Therapy: A Case Report.

Wakabayashi K, Yanagawa H, Hayashi Y, Aoyama R, Shimizu Y, Tomino Y, Suzuki Y.

Case Rep Nephrol Dial. 2019 Feb 8;9(1):1-7. doi: 10.1159/000496465. eCollection 2019 Jan-Apr.

2.

Exercise-Induced Acute Kidney Injury in a Police Officer with Hereditary Renal Hypouricemia.

Shimizu Y, Wakabayashi K, Totsuka A, Hayashi Y, Nitta S, Hara K, Akira M, Tomino Y, Suzuki Y.

Case Rep Nephrol Dial. 2019 Jul 29;9(2):92-101. doi: 10.1159/000501877. eCollection 2019 May-Aug.

3.

The effects of soursop supplementation on blood pressure, serum uric acid, and kidney function in a prehypertensive population in accordance with the 2017 ACC/AHA guideline.

Alatas H, Sja'bani M, Mustofa M, Mukti AG, Bawazier LA, Irijanto F, Zulaela Z, Tomino Y.

J Hum Hypertens. 2019 Aug 28. doi: 10.1038/s41371-019-0235-6. [Epub ahead of print]

PMID:
31462727
4.

MPGN Type 3 Associated with Pemphigus Herpetiformis Mimicking PGNMID and Dermatitis Herpetiformis.

Shimizu Y, Wakabayashi K, Hayashi Y, Hara K, Aoyama R, Niimi T, Tomino Y, Wada R, Hata M, Suzuki Y.

Case Rep Nephrol Dial. 2019 Mar 21;9(1):15-24. doi: 10.1159/000498939. eCollection 2019 Jan-Apr.

5.

Neurofilament heavy polypeptide protects against reduction in synaptopodin expression and prevents podocyte detachment.

Wang J, Hidaka T, Sasaki Y, Tanaka E, Takagi M, Shibata T, Kubo A, Trejo JAO, Wang L, Asanuma K, Tomino Y.

Sci Rep. 2018 Nov 21;8(1):17157. doi: 10.1038/s41598-018-35465-6.

6.

A grading system that predicts the risk of dialysis induction in IgA nephropathy patients based on the combination of the clinical and histological severity.

Okonogi H, Kawamura T, Joh K, Koike K, Miyazaki Y, Ogura M, Tsuboi N, Hirano K, Matsushima M, Yokoo T, Horikoshi S, Suzuki Y, Yasuda T, Shirai S, Shibata T, Hattori M, Akioka Y, Katafuchi R, Hashiguchi A, Hisano S, Shimizu A, Kimura K, Maruyama S, Matsuo S, Tomino Y; Special IgA Nephropathy Study Group.

Clin Exp Nephrol. 2019 Jan;23(1):16-25. doi: 10.1007/s10157-018-1657-0. Epub 2018 Oct 26. Review.

7.

How to treat patients with chronic kidney disease: With special focus on IgA nephropathy.

Tomino Y.

Nephrology (Carlton). 2018 Oct;23 Suppl 4:76-79. doi: 10.1111/nep.13471. Review.

PMID:
30298660
8.

Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.

Liu WC, Tomino Y, Lu KC.

Toxins (Basel). 2018 Sep 11;10(9). pii: E367. doi: 10.3390/toxins10090367. Review.

9.

Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.

Kimura K, Hosoya T, Uchida S, Inaba M, Makino H, Maruyama S, Ito S, Yamamoto T, Tomino Y, Ohno I, Shibagaki Y, Iimuro S, Imai N, Kuwabara M, Hayakawa H, Ohtsu H, Ohashi Y; FEATHER Study Investigators.

Am J Kidney Dis. 2018 Dec;72(6):798-810. doi: 10.1053/j.ajkd.2018.06.028. Epub 2018 Sep 1.

10.

Importance of AST-120 (Kremezin®) Adherence in a Chronic Kidney Disease Patient with Diabetes.

Tomino Y, Hisada-Urita A, Seki T, Watanabe T, Kanda R, Takahashi T.

Case Rep Nephrol Dial. 2018 Jun 8;8(2):107-111. doi: 10.1159/000489772. eCollection 2018 May-Aug.

11.

Suffocation due to Acute Airway Edema in a Patient with Hereditary Angioedema Highlighted the Need for Urgent Improvements in Treatment Availability in Japan.

Honda D, Ohsawa I, Shimizu Y, Maiguma M, Hidaka T, Suzuki H, Io H, Mano S, Takahara H, Rinno H, Tomino Y, Suzuki Y.

Intern Med. 2018 Nov 1;57(21):3193-3197. doi: 10.2169/internalmedicine.9262-17. Epub 2018 Apr 27.

12.

Rac1 in podocytes promotes glomerular repair and limits the formation of sclerosis.

Asao R, Seki T, Takagi M, Yamada H, Kodama F, Hosoe-Nagai Y, Tanaka E, Trejo JAO, Yamamoto-Nonaka K, Sasaki Y, Hidaka T, Ueno T, Yanagita M, Suzuki Y, Tomino Y, Asanuma K.

Sci Rep. 2018 Mar 22;8(1):5061. doi: 10.1038/s41598-018-23278-6.

13.

Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy.

Yamada K, Huang ZQ, Raska M, Reily C, Anderson JC, Suzuki H, Ueda H, Moldoveanu Z, Kiryluk K, Suzuki Y, Wyatt RJ, Tomino Y, Gharavi AG, Weinmann A, Julian BA, Willey CD, Novak J.

Kidney Int Rep. 2017 Jul 19;2(6):1194-1207. doi: 10.1016/j.ekir.2017.07.002. eCollection 2017 Nov.

14.

Clinical Features of Hereditary and Mast Cell-mediated Angioedema Focusing on the Differential Diagnosis in Japanese Patients.

Ohsawa I, Honda D, Hisada A, Inoshita H, Onda-Tsueshita K, Mano S, Sato N, Nakamura Y, Shimizu T, Gotoh H, Goto Y, Suzuki Y, Tomino Y.

Intern Med. 2018 Feb 1;57(3):319-324. doi: 10.2169/internalmedicine.8624-16. Epub 2017 Nov 1.

15.

Scavenging of reactive oxygen species by astaxanthin inhibits epithelial-mesenchymal transition in high glucose-stimulated mesothelial cells.

Hara K, Hamada C, Wakabayashi K, Kanda R, Kaneko K, Horikoshi S, Tomino Y, Suzuki Y.

PLoS One. 2017 Sep 19;12(9):e0184332. doi: 10.1371/journal.pone.0184332. eCollection 2017.

16.

Re-expression of Sall1 in podocytes protects against adriamycin-induced nephrosis.

Hosoe-Nagai Y, Hidaka T, Sonoda A, Sasaki Y, Yamamoto-Nonaka K, Seki T, Asao R, Tanaka E, Trejo JAO, Kodama F, Takagi M, Tada N, Ueno T, Nishinakamura R, Tomino Y, Asanuma K.

Lab Invest. 2017 Nov;97(11):1306-1320. doi: 10.1038/labinvest.2017.69. Epub 2017 Jul 31.

17.

Diminished capacity of opsonization and immune complex solubilization, and detection of anti-C1q antibodies in sera from patients with hereditary angioedema.

Honda D, Ohsawa I, Sato N, Inoshita H, Mano S, Tomino Y, Suzuki Y.

Allergol Int. 2017 Oct;66(4):603-609. doi: 10.1016/j.alit.2017.03.008. Epub 2017 Apr 20.

18.

Effect of tonsillectomy with steroid pulse therapy on circulating tumor necrosis factor receptors 1 and 2 in IgA nephropathy.

Murakoshi M, Gohda T, Sonoda Y, Suzuki H, Tomino Y, Horikoshi S, Suzuki Y.

Clin Exp Nephrol. 2017 Dec;21(6):1068-1074. doi: 10.1007/s10157-017-1408-7. Epub 2017 Apr 7.

PMID:
28389814
19.

High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophrenia.

Nishimon S, Ohnuma T, Takebayashi Y, Katsuta N, Takeda M, Nakamura T, Sannohe T, Higashiyama R, Kimoto A, Shibata N, Gohda T, Suzuki Y, Yamagishi SI, Tomino Y, Arai H.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jun 2;76:145-154. doi: 10.1016/j.pnpbp.2017.03.006. Epub 2017 Mar 22.

PMID:
28341443
20.

High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia.

Sannohe T, Ohnuma T, Takeuchi M, Tani E, Miki Y, Takeda M, Katsuta N, Takebayashi Y, Nakamura T, Nishimon S, Kimoto A, Higashiyama R, Shibata N, Gohda T, Suzuki Y, Yamagishi SI, Tomino Y, Arai H.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jun 2;76:42-48. doi: 10.1016/j.pnpbp.2017.02.019. Epub 2017 Mar 7.

PMID:
28282638
21.

Sorting Nexin 9 facilitates podocin endocytosis in the injured podocyte.

Sasaki Y, Hidaka T, Ueno T, Akiba-Takagi M, Oliva Trejo JA, Seki T, Nagai-Hosoe Y, Tanaka E, Horikoshi S, Tomino Y, Suzuki Y, Asanuma K.

Sci Rep. 2017 Mar 7;7:43921. doi: 10.1038/srep43921.

22.

Circulating TNF Receptors 1 and 2 Predict Mortality in Patients with End-stage Renal Disease Undergoing Dialysis.

Gohda T, Maruyama S, Kamei N, Yamaguchi S, Shibata T, Murakoshi M, Horikoshi S, Tomino Y, Ohsawa I, Gotoh H, Nojiri S, Suzuki Y.

Sci Rep. 2017 Mar 3;7:43520. doi: 10.1038/srep43520.

23.

Effects of Cardiac Function with Postoperative Arteriovenous Fistula Blood Flow in Patients with Hemodialysis.

Wakabayashi K, Io H, Nakata J, Nakamoto H, Sato M, Sasaki Y, Shimizu Y, Horikoshi S, Tomino Y, Suzuki Y.

Blood Purif. 2017;44(1):24-29. doi: 10.1159/000458146. Epub 2017 Feb 25.

PMID:
28237983
24.

Evaluation of Long-Term Combination Therapy With Peritoneal Dialysis and Hemodialysis.

Kanda R, Io H, Nakata J, Makita Y, Sasaki Y, Matsumoto M, Wakabayashi K, Tomino Y, Suzuki Y.

Ther Apher Dial. 2017 Apr;21(2):180-184. doi: 10.1111/1744-9987.12517. Epub 2017 Feb 10.

PMID:
28185405
25.

Beneficial effects of tonsillectomy plus steroid pulse therapy on inflammatory and tubular markers in patients with IgA nephropathy.

Maruyama S, Gohda T, Suzuki Y, Suzuki H, Sonoda Y, Ichikawa S, Li Z, Murakoshi M, Horikoshi S, Tomino Y.

Kidney Res Clin Pract. 2016 Dec;35(4):233-236. Epub 2016 Sep 16.

26.

Diagnosis and treatment of patients with IgA nephropathy in Japan.

Tomino Y.

Kidney Res Clin Pract. 2016 Dec;35(4):197-203. Epub 2016 Sep 15. Review.

27.

Effect of Predialysis Recombinant Human Erythropoietin on Early Survival After Hemodialysis Initiation in Patients With Chronic Kidney Disease: Co-JET Study.

Watanabe Y, Akizawa T, Saito A, Gejyo F, Suzuki M, Nishizawa Y, Tomino Y, Tsubakihara Y, Akiba T, Hirakata H, Kawanishi H, Bessho M, Udagawa Y, Aoki K, Uemura Y, Ohashi Y; Co-JET Study Group.

Ther Apher Dial. 2016 Dec;20(6):598-607. doi: 10.1111/1744-9987.12425. Epub 2016 Dec 7.

PMID:
27928910
28.

Toll-Like Receptor 9 Stimulation Induces Aberrant Expression of a Proliferation-Inducing Ligand by Tonsillar Germinal Center B Cells in IgA Nephropathy.

Muto M, Manfroi B, Suzuki H, Joh K, Nagai M, Wakai S, Righini C, Maiguma M, Izui S, Tomino Y, Huard B, Suzuki Y.

J Am Soc Nephrol. 2017 Apr;28(4):1227-1238. doi: 10.1681/ASN.2016050496. Epub 2016 Dec 5.

29.

Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.

Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Sasatomi Y, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y; Refractory Nephrotic Syndrome Study Group.

Clin Exp Nephrol. 2017 Dec;21(6):961-970. doi: 10.1007/s10157-016-1340-2. Epub 2016 Oct 25.

30.

Pancreatic lipase activity in overnight effluent predicts high transport status in peritoneal dialysis patients.

Idei M, Tabe Y, Hamada C, Miyake K, Takemura H, Io H, Wakita M, Horii T, Tomino Y, Ohsaka A, Miida T.

Clin Chim Acta. 2016 Nov 1;462:65-70. doi: 10.1016/j.cca.2016.08.009. Epub 2016 Aug 13.

PMID:
27531412
31.

Laparoscope Is a Useful Tool for Reducing and Drawing off a Peritoneal Dialysis Catheter in Peritoneal Dialysis Patients.

Io H, Hara K, Nakata J, Sakamoto K, Tomino Y.

Kidney Int Rep. 2016 Jun 23;1(2):93. doi: 10.1016/j.ekir.2016.06.001. eCollection 2016 Jul. No abstract available.

32.

IgA nephropathy.

Lai KN, Tang SC, Schena FP, Novak J, Tomino Y, Fogo AB, Glassock RJ.

Nat Rev Dis Primers. 2016 Feb 11;2:16001. doi: 10.1038/nrdp.2016.1. Review.

PMID:
27189177
33.

Impact of preoperative ultrasonography findings on the patency rate of vascular access in Japanese hemodialysis patients.

Nakata J, Io H, Watanabe T, Sasaki Y, Makita Y, Aoki T, Yanagawa H, Kanda R, Tomino Y.

Springerplus. 2016 Apr 14;5:462. doi: 10.1186/s40064-016-2082-z. eCollection 2016.

34.

Cathepsin D in Podocytes Is Important in the Pathogenesis of Proteinuria and CKD.

Yamamoto-Nonaka K, Koike M, Asanuma K, Takagi M, Oliva Trejo JA, Seki T, Hidaka T, Ichimura K, Sakai T, Tada N, Ueno T, Uchiyama Y, Tomino Y.

J Am Soc Nephrol. 2016 Sep;27(9):2685-700. doi: 10.1681/ASN.2015040366. Epub 2016 Jan 28.

35.

Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer's patch by cholera toxin B induce the glomerular deposition of IgA.

Yamanaka T, Tamauchi H, Suzuki Y, Suzuki H, Horikoshi S, Terashima M, Iwabuchi K, Habu S, Okumura K, Tomino Y.

Immunobiology. 2016 Apr;221(4):577-85. doi: 10.1016/j.imbio.2015.12.001. Epub 2015 Dec 15.

36.

Predictive factors associated with increased progression to dialysis in early chronic kidney disease (stage 1-3) patients.

Nohara N, Io H, Matsumoto M, Furukawa M, Okumura K, Nakata J, Shimizu Y, Horikoshi S, Tomino Y.

Clin Exp Nephrol. 2016 Oct;20(5):740-747. Epub 2015 Dec 26.

PMID:
26707759
37.

Is the new GFR equation using inulin clearance a more accurate method for Asian patients?

Kim BS, Lee YK, Choi HY, Choi SO, Shin SK, Ha SK, Lee KW, Kim YW, Kim YL, Yasuda Y, Imai E, Horio M, Tomino Y, Matsuo S, Lee HY.

Clin Nephrol. 2015 Dec;84(6):331-8. doi: 10.5414/CN108496.

PMID:
26558368
38.

Patient classification and outcome prediction in IgA nephropathy.

Diciolla M, Binetti G, Di Noia T, Pesce F, Schena FP, Vågane AM, Bjørneklett R, Suzuki H, Tomino Y, Naso D.

Comput Biol Med. 2015 Nov 1;66:278-86. doi: 10.1016/j.compbiomed.2015.09.003. Epub 2015 Sep 25.

PMID:
26453758
39.
40.

Podocyte-specific deletion of Rac1 leads to aggravation of renal injury in STZ-induced diabetic mice.

Ishizaka M, Gohda T, Takagi M, Omote K, Sonoda Y, Oliva Trejo JA, Asao R, Hidaka T, Asanuma K, Horikoshi S, Tomino Y.

Biochem Biophys Res Commun. 2015 Nov 20;467(3):549-55. doi: 10.1016/j.bbrc.2015.09.158. Epub 2015 Oct 21.

PMID:
26435502
41.

Pathogenic Role of a Proliferation-Inducing Ligand (APRIL) in Murine IgA Nephropathy.

Kim YG, Alvarez M, Suzuki H, Hirose S, Izui S, Tomino Y, Huard B, Suzuki Y.

PLoS One. 2015 Sep 8;10(9):e0137044. doi: 10.1371/journal.pone.0137044. eCollection 2015.

42.

Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.

Yasutake J, Suzuki Y, Suzuki H, Hiura N, Yanagawa H, Makita Y, Kaneko E, Tomino Y.

Nephrol Dial Transplant. 2015 Aug;30(8):1315-21. doi: 10.1093/ndt/gfv221. Epub 2015 Jun 23.

43.

Clinical decision support system for end-stage kidney disease risk estimation in IgA nephropathy patients.

Pesce F, Diciolla M, Binetti G, Naso D, Ostuni VC, Di Noia T, Vågane AM, Bjørneklett R, Suzuki H, Tomino Y, Di Sciascio E, Schena FP.

Nephrol Dial Transplant. 2016 Jan;31(1):80-6. doi: 10.1093/ndt/gfv232. Epub 2015 Jun 4.

PMID:
26047632
44.

The Prevalence and Management of Diabetic Nephropathy in Asia.

Tomino Y, Gohda T.

Kidney Dis (Basel). 2015 May;1(1):52-60. doi: 10.1159/000381757. Epub 2015 Apr 30. Review.

45.

Targeted IgA Fc receptor I (FcαRI) therapy in the early intervention and treatment of pristane-induced lupus nephritis in mice.

Liu C, Kanamaru Y, Watanabe T, Tada N, Horikoshi S, Suzuki Y, Liu Z, Tomino Y.

Clin Exp Immunol. 2015 Sep;181(3):407-16. doi: 10.1111/cei.12647. Epub 2015 Jul 2.

46.

TWEAK/Fn14 system and crescent formation in IgA nephropathy.

Sasaki Y, Shimizu Y, Suzuki Y, Horikoshi S, Tomino Y.

BMC Nephrol. 2015 Mar 14;16:27. doi: 10.1186/s12882-015-0022-8.

47.

Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan.

Ohsawa I, Honda D, Nagamachi S, Hisada A, Shimamoto M, Inoshita H, Mano S, Tomino Y.

Ann Allergy Asthma Immunol. 2015 Jun;114(6):492-8. doi: 10.1016/j.anai.2015.03.010. Epub 2015 Apr 11.

PMID:
25872948
48.

Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.

Sonoda Y, Gohda T, Suzuki Y, Omote K, Ishizaka M, Matsuoka J, Tomino Y.

PLoS One. 2015 Apr 10;10(4):e0122212. doi: 10.1371/journal.pone.0122212. eCollection 2015.

49.

Determinants of coronary artery calcification in maintenance hemodialysis patients.

Nishizawa Y, Mizuiri S, Yorioka N, Hamada C, Tomino Y.

J Artif Organs. 2015 Sep;18(3):251-6. doi: 10.1007/s10047-015-0823-3. Epub 2015 Mar 25.

PMID:
25805429
50.

Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia.

Takeda M, Ohnuma T, Takeuchi M, Katsuta N, Maeshima H, Takebayashi Y, Higa M, Nakamura T, Nishimon S, Sannohe T, Hotta Y, Hanzawa R, Higashiyama R, Shibata N, Gohda T, Suzuki Y, Yamagishi S, Tomino Y, Arai H.

Neurosci Lett. 2015 Apr 23;593:51-5. doi: 10.1016/j.neulet.2015.03.002. Epub 2015 Mar 10.

PMID:
25766756

Supplemental Content

Loading ...
Support Center